Drug Class
ALK and ROS1 tyrosine kinase inhibitor
Type
brand
Active Ingredient
crizotinib
📋Overview
Xalkori is a medication primarily used in the management of certain types of non-small cell lung cancer (NSCLC). It targets specific genetic mutations, such as alterations in the ALK or ROS1 genes, which can drive cancer growth. By inhibiting these abnormal proteins, Xalkori helps slow the progression of the disease. It is associated with the field of targeted cancer therapies.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Xalkori
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.